Schedule 13G ownership disclosure
VERTEX PHARMACEUTICALS INC COM
Security class unavailable · CUSIP: 92532F100
Event date: Unavailable
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 7,014,275
- Percent of class
- Unavailable
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001137774-15-000056
- Form type
- SC 13G
- Filer
- PRUDENTIAL FINANCIAL INC
- CIK
- CIK 1137774
- Filed
- Feb 02, 2015
- Reporting period
- —
- Description
- Schedule 13G beneficial ownership